TY - JOUR
T1 - Transcriptional and Cytotoxic Responses of Human Intestinal Organoids to IFN Types I, II, and III
AU - Constant, David A.
AU - Van Winkle, Jacob A.
AU - VanderHoek, Eden
AU - Dekker, Simone E.
AU - Sofia, M. Anthony
AU - Regner, Emilie
AU - Modiano, Nir
AU - Tsikitis, V. Liana
AU - Nice, Timothy J.
N1 - Funding Information:
We thank the following OHSU core facilities for technical support, sample management, and study coordination: the Oregon Clinical and Translational Research Institute, the Integrated Genomics Laboratory, the Flow Cytometry Core, the Advanced Light Microscopy Core, and the OHSU Knight Cancer BioLibrary.
Funding Information:
Received for publication March 29, 2022. Accepted for publication June 14, 2022. Address correspondence and reprint requests to: Dr. Timothy J. Nice and Dr. David A. Constant, Department of Molecular Microbiology and Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland OR 97219. E-mail addresses: nice@ohsu.edu (T.J.N.) and d.a.constant@gmail.com (D.A.C.) ORCIDs: 0000-0001-9656-078X (D.A.C.), 0000-0002-4422-4175 (J.A.V.W.), 0000-0003-1303-6611 (M.A.S.), 0000-0002-5216-2971 (V.L.T.), 0000-0002-4471-7666 (T.J.N.). 1Current address: Absci, Vancouver, WA. RNA sequencing data presented in this article have been submitted to the Gene Expression Omnibus under accession number GSE190899. This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002369 to the Oregon Clinical and Translational Research Center. D.A.C. was supported by National Institutes of Health Grant T32-AI007472, an N.L. Tartar Trust grant from Oregon Health & Science University (OHSU), and the Medical Research Foundation of Oregon (OHSU). T.J.N. was supported by National Institutes of Health Grant R01-AI130055 and by the OHSU School of Medicine Faculty Innovation Fund. S.E.D. was supported by the N.L. Tartar Trust (OHSU). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. D.A.C.: conceptualization, methodology, investigation, analysis, funding acquisition, writing and editing, supervision, project administration, visualization, and data curation. J.A.V.W.: investigation, analysis, visualization, and editing. E.V.: investigation and visualization. S.E.D.: funding acquisition. M.A.S., E.R., N.M., and V.L.T.: resources. T.J.N.: conceptualization, methodology, investigation, analysis, funding acquisition, editing, supervision, and visualization. Abbreviations used in this article: GAS, IFN-g–activated sequence; GEO, Gene Expression Omnibus; IBD, inflammatory bowel disease; IEC, intestinal epithelial cell; IFN-I, IFN type I; IFN-II, IFN type II; IFN-III, IFN type 3; IRF, IFN regulatory factor; ISG, IFN-stimulated gene; ISGF3, ISG factor 3; ISRE, IFN-stimulated response element; KEGG, Kyoto Encyclopedia of Genes and Genomes; OHSU, Oregon Health & Science University; qPCR, quantitative PCR; RCF, relative centrifugal force; RNA-seq, RNA sequencing; TR-FRET, time-resolved fluorescence resonance energy transfer. The online version of this article contains supplemental material. This article is distributed under the terms of the CC BY 4.0 Unported license.
Publisher Copyright:
Copyright © 2022 The Authors
PY - 2022/7/1
Y1 - 2022/7/1
N2 - The three types of IFN have roles in antimicrobial immunity and inflammation that must be properly balanced to maintain tissue homeostasis. For example, IFNs are elevated in the context of inflammatory bowel disease and may synergize with inflammatory cytokines such as TNF-a to promote tissue damage. Prior studies suggest that in mouse intestinal epithelial cells (IECs), type III IFNs are preferentially produced during viral infections and are less cytotoxic than type I IFN. In this study, we generated human IEC organoid lines from biopsies of ileum, ascending colon, and sigmoid colon of three healthy subjects to establish the baseline responses of normal human IECs to types I, II, and III IFN. We found that all IFN types elicited responses that were qualitatively consistent across intestinal biopsy sites. However, IFN types differed in magnitude of STAT1 phosphorylation and identity of genes in their downstream transcriptional programs. Specifically, there was a core transcriptional module shared by IFN types, but types I and II IFN stimulated unique transcriptional modules beyond this core gene signature. The transcriptional modules of type I and II IFN included proapoptotic genes, and expression of these genes correlated with potentiation of TNF-a cytotoxicity. These data define the response profiles of healthy human IEC organoids across IFN types, and they suggest that cytotoxic effects mediated by TNF-a in inflamed tissues may be amplified by a simultaneous high-magnitude IFN response. ImmunoHorizons, 2022, 6: 416–429.
AB - The three types of IFN have roles in antimicrobial immunity and inflammation that must be properly balanced to maintain tissue homeostasis. For example, IFNs are elevated in the context of inflammatory bowel disease and may synergize with inflammatory cytokines such as TNF-a to promote tissue damage. Prior studies suggest that in mouse intestinal epithelial cells (IECs), type III IFNs are preferentially produced during viral infections and are less cytotoxic than type I IFN. In this study, we generated human IEC organoid lines from biopsies of ileum, ascending colon, and sigmoid colon of three healthy subjects to establish the baseline responses of normal human IECs to types I, II, and III IFN. We found that all IFN types elicited responses that were qualitatively consistent across intestinal biopsy sites. However, IFN types differed in magnitude of STAT1 phosphorylation and identity of genes in their downstream transcriptional programs. Specifically, there was a core transcriptional module shared by IFN types, but types I and II IFN stimulated unique transcriptional modules beyond this core gene signature. The transcriptional modules of type I and II IFN included proapoptotic genes, and expression of these genes correlated with potentiation of TNF-a cytotoxicity. These data define the response profiles of healthy human IEC organoids across IFN types, and they suggest that cytotoxic effects mediated by TNF-a in inflamed tissues may be amplified by a simultaneous high-magnitude IFN response. ImmunoHorizons, 2022, 6: 416–429.
UR - http://www.scopus.com/inward/record.url?scp=85133219101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133219101&partnerID=8YFLogxK
U2 - 10.4049/IMMUNOHORIZONS.2200025
DO - 10.4049/IMMUNOHORIZONS.2200025
M3 - Article
C2 - 35790340
AN - SCOPUS:85133219101
SN - 2573-7732
VL - 6
SP - 416
EP - 429
JO - ImmunoHorizons
JF - ImmunoHorizons
IS - 7
ER -